CRBU

NASD Caribou Biosciences, Inc.
Oct 11, 2026 · 7:38 AM ET EOD Market Closed

$0.4602 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4602, $0.0592 below the day’s high of $0.5194

YTD change
-71.06%
vs 20-day SMA
-61.19%
vs 200-day SMA
-73.30%

Price ranges

Previous day
$0.4425 $0.5194
open $0.4600 close $0.4602
+$0.0002 (+0.04%)
Today
$0.4425 $0.5194
$0.4602
Past week
$0.4503 $1.2400
from $1.2200 now $0.4602
-$0.7598 (-62.28%)
Past month
$0.4503 $1.4000
from $1.3700 now $0.4602
-$0.9098 (-66.41%)
This year
$0.4425 $2.4900
from $1.5900 now $0.4602
-$1.1298 (-71.06%)

Price & Performance

-1.49 (-76.40%) / 6M

$0.3026$1.06$1.83$2.59Apr 13Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 98.6% away from all-time highs of $32.6450
  • CRBU is down 71% since the beginning of the year
  • CRBU is down 83% over the past 12 months
  • CRBU is down 66% over the past 1 month
  • 13% of all CRBU investors are betting against CRBU

CRBU reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -80.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.24
Earnings momentum +8.4% Quarterly EPS growth
Quarterly change +8.4%

Valuation

P/E ratio N/A
Enterprise value $-37064700.0
Beta 3.17

Balance sheet & scale

IncomeN/A
Revenue$10.0M
Cash$112.3M
Debt$26.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $49.3M

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $414.87 +1.82%
MRNA Moderna, Inc. $225.00 +14.21%
RVMD Revolution Medicines, Inc. $189.76 +0.87%
ROIV Roivant Sciences Ltd. $35.44 +3.60%
BNTX BioNTech SE Sponsored ADR $96.96 +5.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.